EN
HI
Summary
As of 2 Oct, 2026, Accretion Nutraveda stock price is ₹305. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Accretion Nutraveda has traded between ₹150.10 and ₹313.00.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹305.00.
Accretion Nutraveda has an upper circuit limit of ₹366.00 and a lower circuit limit of ₹244.00. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1000. Accretion Nutraveda also offers a dividend yield of 0%.
Accretion Nutraveda Share Price Chart
Accretion Nutraveda Share Key Metrics
Volume
0.00
Market Cap
220.82 CR
LTQ@LTP
0@305.00
ATP
0
Var Margin
53.5 %
Circuit Range
244-366
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1000
Accretion Nutraveda Resistance and Support
Pivot 300
Resistance
First Resistance
310
Second Resistance
315
Third Resistance
325
Support
First Support
295
Second Support
285
Third Support
280
Accretion Nutraveda Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 30 2026 | 290 | 305 | 4.45% | 305 | 290 |
| Tue Sep 29 2026 | 292 | 292 | 8.23% | 292 | 292 |
| Mon Sep 28 2026 | 270.2 | 269.79 | -0.72% | 270.2 | 269.04 |
Accretion Nutraveda Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-08 | Audited Results |
Accretion Nutraveda News
Accretion Nutraveda Ltd - 544694 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Accretion Nutraveda announced a postal ballot for five special resolutions. These include expanding its MOA to broaden business scope, increasing borrowing limits to ₹500 crores, and approving inter-corporate loans/guarantees/investments up to ₹100 crores to support future growth and operations.
Sep 09 2026 21:19:13
Accretion Nutraveda Ltd - 544694 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Accretion Nutraveda's Board approved significant changes to its Memorandum of Association, expanding its business scope across healthcare, pharma, and agriculture. The board also increased borrowing and charge creation limits, along with approvals for loans/guarantees to interested parties, all subject to shareholder consent.
Sep 02 2026 15:37:39
Accretion Nutraveda Management
| Name | Position |
|---|---|
| Mayur Popatlal Sojitra | Managing Director |
| Ankurkumar Patel | Whole Time Director |
Accretion Nutraveda FAQs
The Buying Price of Accretion Nutraveda share is 305 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Accretion Nutraveda stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Accretion Nutraveda, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Accretion Nutraveda shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Accretion Nutraveda shares is 0. Useful to assess the stock's value relative to its book value.
To assess Accretion Nutraveda’s valuation compare Sector P/E, P/B which are 43.03 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Accretion Nutraveda is 220.82 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Accretion Nutraveda share price is 313.00 & 150.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Accretion Nutraveda belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ANL
